Immatics | Results Presentation Deck | 25 slides

Immatics · 2022-10
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON

Slide inventory

25
every slide · same image gating as the playbook
01
Slide 1
Includes company logo, presenter names, date, and corporate tagline.front_matter
Open slide detailBeat · Problem
02
other
Open slide detailBeat · Problem
03
Includes histological images of PRAME expression and a table of prevalence by indication.size_opportunity
Open slide detailBeat · Problem
04
The slide uses a process flow diagram to show the progression of clinical trial cohorts.plan_implementation
Open slide detailBeat · Problem
05
The slide uses a process flow diagram to illustrate trial cohorts. Cohorts B and C are greyed out, indicating they are not the focus of this specific update.present_framework
Open slide detailBeat · Problem
06
The slide uses a before-after framework to contrast the focus areas of two clinical trial phases, followed by a numbered list of specific improvements.present_solution
Open slide detailBeat · AgitateLoop · Before After
07
The slide uses a process-flow layout to show progression from Phase 1a to 1b to final takeaways.summarize
Open slide detailBeat · AgitateLoop · Before After
08
Includes footnotes defining abbreviations and trial parameters.analyze_data
Open slide detailBeat · AgitateLoop · Before After
09
Data cut-off date is 06-Sept-2022. Includes footnotes regarding patient outcomes and definitions.summarize
Open slide detailBeat · SolutionLoop · Before After
10
Data cut-off 06-Sept-2022. Footnotes define ORR and cORR criteria.analyze_data
Open slide detailBeat · SolutionLoop · Before After
11
The slide uses waterfall charts to visualize clinical trial efficacy across various solid tumor types.analyze_data
Open slide detailBeat · SolutionLoop · Before After
12
Clinical trial data visualization using spider plots (spaghetti plots) to track individual patient tumor burden changes.analyze_data
Open slide detailBeat · SolutionLoop · Before After
13
Includes longitudinal persistence data, peak frequency comparison, and tumor infiltration correlation with clinical response (PD/SD vs PR/cPR).analyze_data
Open slide detailBeat · SolutionLoop · Before After
14
The chart uses a Mann-Whitney U test to compare the two groups (p=0.076).analyze_data
Open slide detailBeat · SolutionLoop · Before After
15
present_solution
Open slide detailBeat · SolutionLoop · Before After
16
The table calculates the addressable patient population by filtering total incidence down to R/R incidence, then applying PRAME positivity and HLA-A*02:01+ prevsize_opportunity
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
17
summarize
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
18
The slide uses a process flow diagram to illustrate clinical trial progression.plan_implementation
Open slide detailLoop · Quick Win Big Bet
19
The slide uses maps to visually represent the geographic distribution of clinical trial sites.other
20
front_matter
21
The slide uses box plots to compare current vs prior manufacturing processes across three key metrics: % CD8+ cells, % transduction, and peak T cell frequency.present_solution
22
The table is split into two columns for space efficiency. Includes detailed footnotes regarding methodology and patient data.analyze_data
23
The slide uses a waterfall chart to visualize clinical trial efficacy data for a specific patient cohort.analyze_data
24
The slide uses box plots with overlaid dot plots to compare PRAME expression levels between PD/SD and PR/cPR response groups, and between Phase 1a and Phase 1b analyze_data
25
The chart uses a vertical dashed line to represent the threshold for PRAME positivity.analyze_data